by palligoelme@gmail.com | Sep 9, 2025 | Clinical Trials
Conditions: Older Patients; Postoperative Care; Intensive Care Unit; Dexmedetomidine; Esketamine; Delirium Interventions: Drug: Dexmedetomidine; Drug: Dexmedetomidine-esketamine combination Sponsors: Peking University First Hospital Not yet recruiting Conditions:...
by palligoelme@gmail.com | Sep 8, 2025 | Clinical Trials
Conditions: IBD (Inflammatory Bowel Disease) Interventions: Drug: Intravenous remimazolam (5 mg initially, with optional 2.5 mg boluses) plus fentanyl (100 mcg) for procedural sedation.; Drug: Intravenous midazolam (3 mg initially, with optional 3 mg boluses) plus...
by palligoelme@gmail.com | Sep 8, 2025 | Clinical Trials
Conditions: Metabolic Abnormality; Metabolic Disorders Interventions: Other: No Intervention: Observational Cohort Sponsors: Amway (China) R&D Center Not yet recruiting Conditions: Metabolic Abnormality; Metabolic Disorders Interventions: Other: No Intervention:...
by palligoelme@gmail.com | Sep 8, 2025 | Clinical Trials
Conditions: Fever; Adverse Event Following Immunisation Interventions: Drug: Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody Sponsors: Duke University; Centers for Disease Control and Prevention; Children’s Hospital Medical Center, Cincinnati;...
by palligoelme@gmail.com | Sep 8, 2025 | Clinical Trials
Conditions: PCOS (Polycystic Ovary Syndrome); Infertility; Anovulation Interventions: Drug: Letrozole (aromatase inhibitor) Sponsors: GABRIEL MONTEIRO PINHEIRO Recruiting Conditions: PCOS (Polycystic Ovary Syndrome); Infertility; Anovulation Interventions: Drug:...
by palligoelme@gmail.com | Sep 5, 2025 | Clinical Trials
Conditions: Liver Transplantation; Tranexamic Acid; End-stage Liver Disease (ESLD) Interventions: Drug: tranexamic acid; Drug: 0.9 % saline Sponsors: RenJi Hospital; West China Hospital; The Affiliated Hospital of Qingdao University; The First Affiliated Hospital of...
